Trevi Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
![]() BCAB
BioAtla, Inc. |
$0.60 | $73.14 M | -0.61 | 65 | $0 |
![]() BOLT
Bolt Biotherapeutics, Inc. |
$0.62 | $29.02 M | -0.46 | 100 | $7.88 M |
![]() CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() CHRS
Coherus BioSciences, Inc. |
$1.62 | $193.89 M | -2.28 | 235 | $266.96 M |
![]() CUE
Cue Biopharma, Inc. |
$1.75 | $71.99 M | -1.38 | 53 | $5.49 M |
![]() CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
![]() FHTX
Foghorn Therapeutics Inc. |
$4.66 | $332.53 M | -2.73 | 112 | $22.60 M |
![]() GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
![]() LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
![]() NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
![]() ORIC
ORIC Pharmaceuticals, Inc. |
$8.32 | $595.34 M | -4.91 | 115 | $0 |
![]() PRLD
Prelude Therapeutics Incorporated |
$1.33 | $205.99 M | -2.02 | 131 | $7.00 M |
![]() RZLT
Rezolute, Inc. |
$5.21 | $229.57 M | -5.02 | 64 | $0 |
![]() SEER
Seer, Inc. |
$2.41 | $112.34 M | -1.34 | 147 | $14.17 M |
![]() SPRO
Spero Therapeutics, Inc. |
$1.08 | $75.85 M | 3.19 | 46 | $96.74 M |
![]() SQZ
SQZ Biotechnologies Company |
$0.44 | $12.83 M | -0.2 | 53 | $21.03 M |
![]() TARA
Protara Therapeutics, Inc. |
$5.85 | $54.98 M | -0.71 | 26 | $0 |
![]() TCON
TRACON Pharmaceuticals, Inc. |
$0.03 | $3.05 M | 0.01 | 17 | $12.05 M |